Piramal Pharma has announced the availability of the transcript from its conference call held on November 6th, 2025, regarding the unaudited financial results (standalone...
NAVA Limited has released its investor presentation for the quarter ended September 30, 2025. The presentation highlights financial performance, including consolidated revenue of ₹989.7...
Alembic Pharmaceuticals has received USFDA final approval for Sumatriptan Injection USP, specifically the 4 mg/0.5 mL and 6 mg/0.5 mL single-dose autoinjector system. This...
Uno Minda announced strong Q2 FY26 results, achieving its highest-ever quarterly revenue and profits. Consolidated revenue reached ₹4,814 Cr, a 13.4% year-over-year increase, while...
NAVA Limited announced robust consolidated financial results, reporting a ₹989.7 crore total income. The company declared an interim dividend of 300% and saw its...
NTPC Green Energy Limited will issue unsecured non-convertible debentures of ₹1,500 crore on November 11, 2025, via private placement. The debentures carry a coupon...
AIA Engineering Limited announces its unaudited financial results for the quarter and half-year ended September 30, 2025. The company reported a total income from...
MCX released its investor presentation for the quarter and half year ended September 30, 2025. The presentation highlights a consolidated performance, showcasing significant increases...
